Insider Buying: Dr. Martens plc (LON:DOCS) Insider Acquires 194 Shares of Stock

Key Points

• Insider Ije Nwokori purchased 194 shares of Dr. Martens plc at an average cost of GBX 77 ($1.03) per share in a transaction totaling £149.38 ($200.64).
• Dr. Martens' stock price increased by 0.6% to GBX 75.60 during mid-day trading, with a volume of 347,907 shares exchanged.
• Equities research analysts have issued mixed ratings for Dr. Martens, with Deutsche Bank reaffirming a "hold" and Royal Bank of Canada reducing their price target significantly.

Dr. Martens plc (LON:DOCS - Get Free Report) insider Ije Nwokori bought 194 shares of the firm's stock in a transaction on Monday, August 11th. The stock was purchased at an average cost of GBX 77 ($1.03) per share, for a total transaction of £149.38 ($200.64).

Ije Nwokori also recently made the following trade(s):

• On Friday, July 11th, Ije Nwokori bought 194 shares of Dr. Martens stock. The stock was purchased at an average cost of GBX 77 ($1.03) per share, for a total transaction of £149.38 ($200.64).
• On Wednesday, June 11th, Ije Nwokori bought 189 shares of Dr. Martens stock. The stock was purchased at an average cost of GBX 79 ($1.06) per share, for a total transaction of £149.31 ($200.55).

Dr. Martens Trading Up 0.6%

LON:DOCS traded up GBX 0.45 ($0.01) during mid-day trading on Tuesday, hitting GBX 75.60 ($1.02). 347,907 shares of the company's stock were exchanged, compared to its average volume of 1,968,943. The company has a 50 day simple moving average of GBX 76.91 and a 200-day simple moving average of GBX 65.13. The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 127.27. Dr. Martens plc has a fifty-two week low of GBX 43.02 ($0.58) and a fifty-two week high of GBX 85.41 ($1.15). The firm has a market capitalization of £733.90 million, a P/E ratio of 10.72, a PEG ratio of 6.40 and a beta of 0.11.

Dr. Martens (LON:DOCS - Get Free Report) last posted its earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) EPS for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. As a group, research analysts expect that Dr. Martens plc will post 2.5809394 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on DOCS shares. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating on shares of Dr. Martens in a report on Friday, July 11th. Royal Bank Of Canada decreased their price target on shares of Dr. Martens from GBX 7,000 ($94.02) to GBX 6,000 ($80.59) and set a "sector perform" rating on the stock in a report on Monday, May 19th.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.